{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:59:09Z","timestamp":1788580749464,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>X-linked hypophosphatemic rickets (XLH) is characterized by increased circulating fibroblast growth factor 23 (FGF23) concentration caused by <jats:italic>PHEX<\/jats:italic> (NM_000444.5) mutations. Renal tubular resorption of phosphate is impaired, resulting in rickets and impaired bone mineralization. By phenotypic-genetic linkage analysis, two <jats:italic>PHEX<\/jats:italic> pathogenic mutations were found in two XLH families: c.433\u2009G\u2009&gt;\u2009T, p.Glu145* in exon 4 and c.2245\u2009T\u2009&gt;\u2009C, p.Trp749Arg in exon 22. Immunofluorescence showed that the localization of p.Glu145* and p.Trp749Arg mutant and secretory PHEX (secPHEX) changed, with decreased expression. In a HEK293T cell model co-transfected with <jats:italic>PHEX<\/jats:italic>, sec<jats:italic>PHEX<\/jats:italic>, and <jats:italic>FGF23<\/jats:italic>, wild-type PHEX, secPHEX, and FGF23 proteins were distributed in the cell membrane or endoplasmic reticulum, while the mutant was located in the nuclear membrane and cytoplasm. qPCR of p.Glu145* revealed decreased <jats:italic>PHEX<\/jats:italic> and sec<jats:italic>PHEX<\/jats:italic> mRNA expression in cells, with no difference in mRNA expression of p.Trp749Arg. Both mutations decreased intracellular PHEX endopeptidase activity. Western blot analysis showed decrease in mutant and secPHEX protein expression and no FGF23 protein expression in single-transfected PHEX and secPHEX cells. In cells co-transfected with FGF23, <jats:italic>PHEX<\/jats:italic> and sec<jats:italic>PHEX<\/jats:italic> mutation promoted FGF23 expression. Dual-luciferase reporter gene was used to detect the effect of <jats:italic>PHEX<\/jats:italic> on <jats:italic>FGF23<\/jats:italic> promoter. The dual-luciferase reporter gene showed that after PHEX overexpression, the activity of mutant firefly luciferase was significantly higher than that of wild type. The regulatory mechanism between PHEX and FGF23 is still unclear, but we found that PHEX is a direct transcriptional inhibitor of FGF23 and affects the expression of FGF23. This study verified the pathogenicity of the two variants and revealed the possible regulatory mechanism between PHEX and FGF23.<\/jats:p>","DOI":"10.1038\/s41419-022-04969-5","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T08:06:08Z","timestamp":1654157168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Function of PHEX mutations p.Glu145* and p.Trp749Arg in families with X-linked hypophosphatemic rickets by the negative regulation mechanism on FGF23 promoter transcription"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-1242","authenticated-orcid":false,"given":"Yu-mian","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-dan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-fu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-bo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-sheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-8470","authenticated-orcid":false,"given":"Fa-qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4271-4848","authenticated-orcid":false,"given":"Jie-wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"4969_CR1","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1210\/jc.2002-021809","volume":"88","author":"Y Sabbagh","year":"2003","unstructured":"Sabbagh Y, Boileau G, Campos M, Carmona AK, Tenenhouse HS. Structure and function of disease-causing missense mutations in the PHEX gene. J Clin Endocrinol Metab. 2003;88:2213\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"4969_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41439-019-0040-3","volume":"6","author":"S Sako","year":"2019","unstructured":"Sako S, Niida Y, Shima KR, Takeshita Y, Ishii KA, Takamura T. A novel PHEX mutation associated with vitamin D-resistant rickets. Hum Genome Var. 2019;6:9.","journal-title":"Hum Genome Var"},{"key":"4969_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11154-017-9408-1","volume":"18","author":"R Fuente","year":"2017","unstructured":"Fuente R, Gil-Pena H, Claramunt-Taberner D, Hernandez O, Fernandez-Iglesias A, Alonso-Duran L, et al. X-linked hypophosphatemia and growth. Rev Endocr Metab Disord. 2017;18:107\u201315.","journal-title":"Rev Endocr Metab Disord"},{"key":"4969_CR4","doi-asserted-by":"publisher","first-page":"e11453","DOI":"10.1097\/MD.0000000000011453","volume":"97","author":"Y Gao","year":"2018","unstructured":"Gao Y, Wang ZM, Li XL. Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: Two case reports. Med (Baltim). 2018;97:e11453.","journal-title":"Med (Baltim)"},{"key":"4969_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen SS, Mughal Z, Haffner D, Nilsson O, Levtchenko E, Ariceta G, et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis. 2019;14:58.","journal-title":"Orphanet J Rare Dis"},{"key":"4969_CR6","doi-asserted-by":"crossref","unstructured":"The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet. 1995,11:130\u20136.","DOI":"10.1038\/ng1095-130"},{"key":"4969_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2265.2010.03919.x","volume":"74","author":"MD Ruppe","year":"2011","unstructured":"Ruppe MD, Brosnan PG, Au KS, Tran PX, Dominguez BW, Northrup H. Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clin Endocrinol (Oxf). 2011;74:312\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4969_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3892\/ijmm.2016.2796","volume":"38","author":"SS Li","year":"2016","unstructured":"Li SS, Gu JM, Yu WJ, He JW, Fu WZ, Zhang ZL. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets. Int J Mol Med. 2016;38:1703\u201314.","journal-title":"Int J Mol Med"},{"key":"4969_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K","volume":"23","author":"AJ Turner","year":"2001","unstructured":"Turner AJ, Isaac RE, Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays. 2001;23:261\u20139.","journal-title":"Bioessays"},{"key":"4969_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.4048938","volume":"230","author":"WT Wickner","year":"1985","unstructured":"Wickner WT, Lodish HF. Multiple mechanisms of protein insertion into and across membranes. Science. 1985;230:400\u20137.","journal-title":"Science"},{"key":"4969_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/bj3550707","volume":"355","author":"G Boileau","year":"2001","unstructured":"Boileau G, Tenenhouse HS, Desgroseillers L, Crine P. Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors. Biochem J. 2001;355:707\u201313.","journal-title":"Biochem J"},{"key":"4969_CR12","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","volume":"14","author":"SK Murali","year":"2016","unstructured":"Murali SK, Andrukhova O, Clinkenbeard EL, White KE, Erben RG. Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice. PLoS Biol. 2016;14:e1002427.","journal-title":"PLoS Biol"},{"key":"4969_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/geno.1996.0421","volume":"36","author":"L Du","year":"1996","unstructured":"Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, Ecarot B. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics. 1996;36:22\u201328.","journal-title":"Genomics"},{"key":"4969_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/002215549804600405","volume":"46","author":"AF Ruchon","year":"1998","unstructured":"Ruchon AF, Marcinkiewicz M, Siegfried G, Tenenhouse HS, DesGroseillers L, Crine P, et al. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem. 1998;46:459\u201368.","journal-title":"J Histochem Cytochem"},{"key":"4969_CR15","first-page":"722","volume":"118","author":"B Yuan","year":"2008","unstructured":"Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, et al. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest. 2008;118:722\u201334.","journal-title":"J Clin Invest"},{"key":"4969_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.bone.2006.12.062","volume":"40","author":"S Fukumoto","year":"2007","unstructured":"Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23. Bone. 2007;40:1190\u20135.","journal-title":"Bone"},{"key":"4969_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00223-015-0029-y","volume":"98","author":"S Fukumoto","year":"2016","unstructured":"Fukumoto S. FGF23-FGF receptor\/Klothopathway as a new drug target for disorders of bone and mineral metabolism. Calcif Tissue Int. 2016;98:334\u201340.","journal-title":"Calcif Tissue Int"},{"key":"4969_CR18","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology. 2004;145:3087\u201394.","journal-title":"Endocrinology"},{"key":"4969_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561\u20138.","journal-title":"J Clin Invest"},{"key":"4969_CR20","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N. Engl J Med. 2003;348:1656\u201363.","journal-title":"N. Engl J Med"},{"key":"4969_CR21","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","volume":"295","author":"S Liu","year":"2008","unstructured":"Liu S, Zhou J, Tang W, Menard R, Feng JQ, Quarles LD. Pathogenic role of Fgf23 in Dmp1-null mice. Am J Physiol Endocrinol Metab. 2008;295:E254\u2013261.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4969_CR22","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/humu.23649","volume":"39","author":"DB Zastrow","year":"2018","unstructured":"Zastrow DB, Baudet H, Shen W, Thomas A, Si Y, Weaver MA, et al. Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene. Hum Mutat. 2018;39:1569\u201380.","journal-title":"Hum Mutat"},{"key":"4969_CR23","first-page":"2661","volume":"25","author":"T Sui","year":"2016","unstructured":"Sui T, Yuan L, Liu H, Chen M, Deng J, Wang Y, et al. CRISPR\/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH). Hum Mol Genet. 2016;25:2661\u201371.","journal-title":"Hum Mol Genet"},{"key":"4969_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Carpenter TO, Gottesman GS, Mao M, Skrinar A, San Martin J, et al. Efficacy and safety of burosumab in children aged 1\u20134\u2009years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. Lancet Diabetes Endocrinol. 2019;7:189\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4969_CR25","doi-asserted-by":"crossref","unstructured":"Lambert AS, Zhukouskaya V, Rothenbuhler A, Linglart A. X-linked hypophosphatemia: management and treatment prospects. Joint Bone Spine. 2019;86:731\u20138.","DOI":"10.1016\/j.jbspin.2019.01.012"},{"key":"4969_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","volume":"35","author":"A Benet-Pages","year":"2004","unstructured":"Benet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM. FGF23 is processed by proprotein convertases but not by PHEX. Bone. 2004;35:455\u201362.","journal-title":"Bone"},{"key":"4969_CR27","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1359\/jbmr.080601","volume":"23","author":"WN Addison","year":"2008","unstructured":"Addison WN, Nakano Y, Loisel T, Crine P, McKee MD. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Min Res. 2008;23:1638\u201349.","journal-title":"J Bone Min Res"},{"key":"4969_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/154411130401500503","volume":"15","author":"PS Rowe","year":"2004","unstructured":"Rowe PS. The wrickkened pathways of FGF23, MEPE and PHEX. Crit Rev Oral Biol Med: Off Publ Am Assoc Oral Biologists. 2004;15:264\u201381.","journal-title":"Crit Rev Oral Biol Med: Off Publ Am Assoc Oral Biologists"},{"key":"4969_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jsb.2013.04.003","volume":"183","author":"F Nudelman","year":"2013","unstructured":"Nudelman F, Lausch AJ, Sommerdijk NA, Sone ED. In vitro models of collagen biomineralization. J Struct Biol. 2013;183:258\u201369.","journal-title":"J Struct Biol"},{"key":"4969_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.bone.2008.06.002","volume":"43","author":"S Ichikawa","year":"2008","unstructured":"Ichikawa S, Traxler EA, Estwick SA, Curry LR, Johnson ML, Sorenson AH, et al. Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone. 2008;43:663\u20136.","journal-title":"Bone"},{"key":"4969_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00223-007-9067-4","volume":"81","author":"W Xia","year":"2007","unstructured":"Xia W, Meng X, Jiang Y, Li M, Xing X, Pang L, et al. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets. Calcif Tissue Int. 2007;81:415\u201320.","journal-title":"Calcif Tissue Int"},{"key":"4969_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gene.2015.03.066","volume":"565","author":"Y Huang","year":"2015","unstructured":"Huang Y, Mei L, Pan Q, Tan H, Quan Y, Gui B, et al. Novel de novo nonsense mutation of the PHEX gene (p.Lys50Ter) in a Chinese patient with hypophosphatemic rickets. Gene. 2015;565:150\u20134.","journal-title":"Gene"},{"key":"4969_CR33","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 2001;60:2079\u201386.","journal-title":"Kidney Int"},{"key":"4969_CR34","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1681\/ASN.2013101076","volume":"25","author":"R Scanni","year":"2014","unstructured":"Scanni R, vonRotz M, Jehle S, Hulter HN, Krapf R. The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol. 2014;25:2730\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"4969_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.3327","volume":"33","author":"D Tokarz","year":"2018","unstructured":"Tokarz D, Martins JS, Petit ET, Lin CP, Demay MB, Liu ES. Hormonal regulation of osteocyte perilacunar and canalicular remodeling in the Hyp mouse model of X-linked hypophosphatemia. J Bone Min Res. 2018;33:499\u2013509.","journal-title":"J Bone Min Res"},{"key":"4969_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.50","volume":"22","author":"PS Rowe","year":"2012","unstructured":"Rowe PS. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr. 2012;22:61\u201386.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"4969_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jbmr.1738","volume":"28","author":"B Yuan","year":"2013","unstructured":"Yuan B, Feng JQ, Bowman S, Liu Y, Blank RD, Lindberg I, et al. Hexa-D-arginine treatment increases 7B2*PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Min Res. 2013;28:56\u201372.","journal-title":"J Bone Min Res"},{"key":"4969_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bone.2015.12.055","volume":"84","author":"H Yamamoto","year":"2016","unstructured":"Yamamoto H, Ramos-Molina B, Lick AN, Prideaux M, Albornoz V, Bonewald L, et al. Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition. Bone. 2016;84:120\u201330.","journal-title":"Bone"},{"key":"4969_CR39","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/boneres.2016.11","volume":"4","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Doucet M, Tomlinson RE, Han X, Quarles LD, Collins MT, et al. The hypoxia-inducible factor-1alpha activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia. Bone Res. 2016;4:16011.","journal-title":"Bone Res"},{"key":"4969_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","volume":"25","author":"C Francis","year":"2016","unstructured":"Francis C, David V. Inflammation regulates fibroblast growth factor 23 production. Curr Opin Nephrol Hypertens. 2016;25:325\u201332.","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04969-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:57:36Z","timestamp":1669301856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["4969"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04969-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}